Phase 2 Trial of V-5 Immunitor (V5) in Patients with Chronic Hepatitis C Co-infected with HIV and Mycobacterium Tuberculosis

Olga V. Arjanova, Nathalia D. Prihoda, Larisa V. Yurchenko, Nina I. Sokolenko, Valery M. Frolov
2010 Journal of Vaccines & Vaccination  
doi:10.4172/2157-7560.1000103 fatcat:7ruzczbahbbe7pntqnvcgmaaoa